デフォルト表紙
市場調査レポート
商品コード
1304057

敗血症診断市場:検査タイプ、技術、製品、方法、病原体、エンドユーザー別-2023-2030年の世界予測

Sepsis Diagnostic Market by Testing Type, Technology, Product, Method, Pathogen, End-user - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 189 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.85円
敗血症診断市場:検査タイプ、技術、製品、方法、病原体、エンドユーザー別-2023-2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 189 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

敗血症診断の世界市場は、2023年にCAGR 9.96%で5億5,686万米ドル、2030年には10億8,417万米ドルに達すると予測され、大きな成長が見込まれています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の敗血症診断市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します:

1.市場の浸透度:主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展:有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化:新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向:COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報:主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション:将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします:

1.敗血症診断の世界市場規模および予測は?

2.予測期間中、世界の敗血症診断市場を形成するCOVID-19の阻害要因と影響は?

3.敗血症診断の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は?

4.敗血症診断の世界市場における競争戦略は?

5.敗血症診断の世界市場における技術動向と規制の枠組みは?

6.敗血症診断の世界市場における主要ベンダーの市場シェアは?

7.敗血症診断の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 敗血症の発生率と有病率の増加
      • 増加する病院感染
      • 技術開発先進的な診断ソリューション
    • 抑制要因
      • 資本集約型の自動診断サービスと償還不足の状況
    • 機会
      • 世界の迅速診断の新たな開発
      • 敗血症診断のための新規バイオマーカーの開発
    • 課題
      • 手順に関する認識と標準手順の欠如
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 敗血症診断市場テストタイプ別

  • 臨床検査
  • PoCテスト

第7章 敗血症診断市場:技術別

  • フローサイトメトリー
  • 免疫学的検査
  • 微生物学
  • 分子診断学

第8章 敗血症診断市場:製品別

  • アッセイキットと試薬
  • 血液培養培地
  • 機器
  • ソフトウェア

第9章 敗血症診断市場:方法別

  • 自動診断
  • 従来の診断

第10章 敗血症診断市場病原体別

  • 細菌性敗血症
    • グラム陰性菌
    • グラム陽性菌
  • 真菌性敗血症

第11章 敗血症診断市場:エンドユーザー別

  • 病院
  • 病理学および基準研究所
  • 調査および学術機関

第12章 南北アメリカの敗血症診断市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第13章 アジア太平洋地域の敗血症診断市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第14章 欧州・中東・アフリカの敗血症診断市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第15章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析:主要企業別
  • 競合シナリオ分析:主要企業別

第16章 掲載企業一覧

第17章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. SEPSIS DIAGNOSTIC MARKET RESEARCH PROCESS
  • FIGURE 2. SEPSIS DIAGNOSTIC MARKET SIZE, 2022 VS 2030
  • FIGURE 3. SEPSIS DIAGNOSTIC MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2022 VS 2030 (%)
  • FIGURE 5. SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
  • FIGURE 6. SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 7. SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2022 VS 2030 (%)
  • FIGURE 8. SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2022 VS 2030 (%)
  • FIGURE 9. SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 10. SEPSIS DIAGNOSTIC MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 11. SEPSIS DIAGNOSTIC MARKET DYNAMICS
  • FIGURE 12. SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 22. SEPSIS DIAGNOSTIC MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 23. SEPSIS DIAGNOSTIC MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. SEPSIS DIAGNOSTIC MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. SEPSIS DIAGNOSTIC MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 5. SEPSIS DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. SEPSIS DIAGNOSTIC MARKET SIZE, BY POC TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. SEPSIS DIAGNOSTIC MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. SEPSIS DIAGNOSTIC MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. SEPSIS DIAGNOSTIC MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 13. SEPSIS DIAGNOSTIC MARKET SIZE, BY ASSAY KITS AND REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. SEPSIS DIAGNOSTIC MARKET SIZE, BY BLOOD CULTURE MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 18. SEPSIS DIAGNOSTIC MARKET SIZE, BY AUTOMATED DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. SEPSIS DIAGNOSTIC MARKET SIZE, BY CONVENTIONAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 21. SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 22. SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. SEPSIS DIAGNOSTIC MARKET SIZE, BY GRAM-NEGATIVE BACTERIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. SEPSIS DIAGNOSTIC MARKET SIZE, BY GRAM-POSITIVE BACTERIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. SEPSIS DIAGNOSTIC MARKET SIZE, BY FUNGAL SEPSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOLOGY & REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. SEPSIS DIAGNOSTIC MARKET SIZE, BY RESEARCH LABORATORIES & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. INDONESIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. INDONESIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 105. INDONESIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. INDONESIA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 107. INDONESIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 114. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. MALAYSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. MALAYSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. MALAYSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. MALAYSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 121. MALAYSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 122. MALAYSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. PHILIPPINES SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. PHILIPPINES SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 126. PHILIPPINES SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. PHILIPPINES SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 128. PHILIPPINES SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SINGAPORE SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SINGAPORE SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. SINGAPORE SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SINGAPORE SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 135. SINGAPORE SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 136. SINGAPORE SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. SOUTH KOREA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. SOUTH KOREA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. SOUTH KOREA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. SOUTH KOREA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 142. SOUTH KOREA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. TAIWAN SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. TAIWAN SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. TAIWAN SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. TAIWAN SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 149. TAIWAN SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 150. TAIWAN SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. THAILAND SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. THAILAND SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 154. THAILAND SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. THAILAND SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 156. THAILAND SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 157. THAILAND SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. VIETNAM SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. VIETNAM SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 161. VIETNAM SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. VIETNAM SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 163. VIETNAM SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 164. VIETNAM SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 176. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 178. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 179. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. EGYPT SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. EGYPT SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. EGYPT SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. EGYPT SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 185. EGYPT SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 186. EGYPT SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. FINLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. FINLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 190. FINLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. FINLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 192. FINLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 193. FINLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. FRANCE SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. FRANCE SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. FRANCE SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. FRANCE SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 199. FRANCE SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 200. FRANCE SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 202. GERMANY SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. GERMANY SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 204. GERMANY SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. GERMANY SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 206. GERMANY SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 207. GERMANY SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 209. ISRAEL SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. ISRAEL SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 211. ISRAEL SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. ISRAEL SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 213. ISRAEL SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 214. ISRAEL SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 216. ITALY SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. ITALY SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 218. ITALY SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. ITALY SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 220. ITALY SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 221. ITALY SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 223. NETHERLANDS SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. NETHERLANDS SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 225. NETHERLANDS SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. NETHERLANDS SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 227. NETHERLANDS SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 228. NETHERLANDS SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. NIGERIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. NIGERIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 232. NIGERIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. NIGERIA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 234. NIGERIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 235. NIGERIA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 237. NORWAY SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. NORWAY SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 239. NORWAY SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 240. NORWAY SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 241. NORWAY SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 242. NORWAY SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 244. POLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. POLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 246. POLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 247. POLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 248. POLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 249. POLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 251. QATAR SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 252. QATAR SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 253. QATAR SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 254. QATAR SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 255. QATAR SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 256. QATAR SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 258. RUSSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 259. RUSSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 260. RUSSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 261. RUSSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 262. RUSSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 263. RUSSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 265. SAUDI ARABIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 266. SAUDI ARABIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 267. SAUDI ARABIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 268. SAUDI ARABIA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 269. SAUDI ARABIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 270. SAUDI ARABIA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 272. SOUTH AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. SOUTH AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 274. SOUTH AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 275. SOUTH AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 276. SOUTH AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 277. SOUTH AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 279. SPAIN SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 280. SPAIN SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 281. SPAIN SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 282. SPAIN SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 283. SPAIN SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 284. SPAIN SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 285. SPAIN SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 286. SWEDEN SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 287. SWEDEN SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 288. SWEDEN SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 289. SWEDEN SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 290. SWEDEN SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 291. SWEDEN SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 292. SWEDEN SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 293. SWITZERLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 294. SWITZERLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 295. SWITZERLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 296. SWITZERLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 297. SWITZERLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 298. SWITZERLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 299. SWITZERLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 300. TURKEY SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 301. TURKEY SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 302. TURKEY SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 303. TURKEY SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 304. TURKEY SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 305. TURKEY SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 306. TURKEY SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 307. UNITED ARAB EMIRATES SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 308. UNITED ARAB EMIRATES SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 309. UNITED ARAB EMIRATES SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 310. UNITED ARAB EMIRATES SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 311. UNITED ARAB EMIRATES SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 312. UNITED ARAB EMIRATES SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 313. UNITED ARAB EMIRATES SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 314. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 315. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 316. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 321. SEPSIS DIAGNOSTIC MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 322. SEPSIS DIAGNOSTIC MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 323. SEPSIS DIAGNOSTIC MARKET LICENSE & PRICING
目次
Product Code: MRR-A339DAEFABB5

The Global Sepsis Diagnostic Market is forecasted to grow significantly, with a projected USD 556.86 million in 2023 at a CAGR of 9.96% and expected to reach a staggering USD 1,084.17 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Sepsis Diagnostic Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Sepsis Diagnostic Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Testing Type, market is studied across Laboratory Testing and PoC Testing. The Laboratory Testing commanded largest market share of 76.43% in 2022, followed by PoC Testing.

Based on Technology, market is studied across Flow Cytometry, Immunoassays, Microbiology, and Molecular Diagnostics. The Microbiology commanded largest market share of 32.78% in 2022, followed by Molecular Diagnostics.

Based on Product, market is studied across Assay Kits and Reagents, Blood Culture Media, Instruments, and Software. The Blood Culture Media commanded largest market share of 37.11% in 2022, followed by Assay Kits and Reagents.

Based on Method, market is studied across Automated Diagnostics and Conventional Diagnostics. The Conventional Diagnostics commanded largest market share of 69.37% in 2022, followed by Automated Diagnostics.

Based on Pathogen, market is studied across Bacterial Sepsis and Fungal Sepsis. The Bacterial Sepsis is further studied across Gram-Negative Bacteria and Gram-Positive Bacteria. The Fungal Sepsis commanded largest market share of 64.79% in 2022, followed by Bacterial Sepsis.

Based on End-user, market is studied across Hospitals, Pathology & Reference Laboratories, and Research Laboratories & Academic Institutes. The Hospitals commanded largest market share of 48.17% in 2022, followed by Pathology & Reference Laboratories.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 42.40% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Sepsis Diagnostic Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Sepsis Diagnostic Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Sepsis Diagnostic Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Sepsis Diagnostic Market?

4. What is the competitive strategic window for opportunities in the Global Sepsis Diagnostic Market?

5. What are the technology trends and regulatory frameworks in the Global Sepsis Diagnostic Market?

6. What is the market share of the leading vendors in the Global Sepsis Diagnostic Market?

7. What modes and strategic moves are considered suitable for entering the Global Sepsis Diagnostic Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Sepsis Diagnostic Market, by Testing Type, 2022 vs 2030
  • 4.3. Sepsis Diagnostic Market, by Technology, 2022 vs 2030
  • 4.4. Sepsis Diagnostic Market, by Product, 2022 vs 2030
  • 4.5. Sepsis Diagnostic Market, by Method, 2022 vs 2030
  • 4.6. Sepsis Diagnostic Market, by Pathogen, 2022 vs 2030
  • 4.7. Sepsis Diagnostic Market, by End-user, 2022 vs 2030
  • 4.8. Sepsis Diagnostic Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing Incidence and Prevalence of Sepsis
      • 5.1.1.2. Growing Occurrence of Hospital Derived Infections
      • 5.1.1.3. Development of Technology Advanced Diagnostic Solutions
    • 5.1.2. Restraints
      • 5.1.2.1. Capital Intensive Automated Diagnostic Services and Dearth of Reimbursement Situations
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging Development of Rapid Diagnostics Globally
      • 5.1.3.2. Development of Novel Biomarkers for Sepsis Diagnostics
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of Awareness and Standard Protocols for the Procedure
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Sepsis Diagnostic Market, by Testing Type

  • 6.1. Introduction
  • 6.2. Laboratory Testing
  • 6.3. PoC Testing

7. Sepsis Diagnostic Market, by Technology

  • 7.1. Introduction
  • 7.2. Flow Cytometry
  • 7.3. Immunoassays
  • 7.4. Microbiology
  • 7.5. Molecular Diagnostics

8. Sepsis Diagnostic Market, by Product

  • 8.1. Introduction
  • 8.2. Assay Kits and Reagents
  • 8.3. Blood Culture Media
  • 8.4. Instruments
  • 8.5. Software

9. Sepsis Diagnostic Market, by Method

  • 9.1. Introduction
  • 9.2. Automated Diagnostics
  • 9.3. Conventional Diagnostics

10. Sepsis Diagnostic Market, by Pathogen

  • 10.1. Introduction
  • 10.2. Bacterial Sepsis
    • 10.2.1. Gram-Negative Bacteria
    • 10.2.2. Gram-Positive Bacteria
  • 10.3. Fungal Sepsis

11. Sepsis Diagnostic Market, by End-user

  • 11.1. Introduction
  • 11.2. Hospitals
  • 11.3. Pathology & Reference Laboratories
  • 11.4. Research Laboratories & Academic Institutes

12. Americas Sepsis Diagnostic Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Sepsis Diagnostic Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Sepsis Diagnostic Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. FPNV Positioning Matrix
  • 15.2. Market Share Analysis, By Key Player
  • 15.3. Competitive Scenario Analysis, By Key Player

16. List of Company Mentioned

17. Appendix

  • 17.1. Discussion Guide
  • 17.2. License & Pricing